Menu Search
Equities

Nfl Biosciences SAS

  • Add to watchlist
  • Add to portfolio
  • Add an alert
82F:FRA

Nfl Biosciences SAS

Actions
  • Price (EUR)1.04
  • Today's Change0.006 / 0.58%
  • Shares traded4.78k
  • 1 Year change-38.43%
  • Beta1.5418
Data delayed at least 15 minutes, as of Feb 16 2026 07:12 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Nfl Biosciences SAS is a France-based company which provides botanical pharmaceutical services. The Company's products help cure addictions through an approach based on botanical pharmaceutical agents. It develops NFL-101, a patented, botanical drug candidate that aims at increasing the odds of quitting for smokers willing to quit. The Company applies scientific approach to other drug candidate with an initial focus targeting the growing addiction to cannabis.

  • Revenue in EUR (TTM)0.00
  • Net income in EUR-3.15m
  • Incorporated2006
  • Employees4.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.